Package 68788-8247-1

{"route": ["TOPICAL"], "spl_id": "39622b79-6854-4436-a668-25d11c8f3198", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197312"], "spl_set_id": ["c11c1136-7421-48ff-86d2-39507e80a04c"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc"]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (68788-8247-1)  / 15 g in 1 TUBE", "package_ndc": "68788-8247-1", "marketing_start_date": "20220819"}], "brand_name": "acyclovir", "product_id": "68788-8247_39622b79-6854-4436-a668-25d11c8f3198", "dosage_form": "OINTMENT", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68788-8247", "generic_name": "acyclovir", "labeler_name": "Preferred Pharmaceuticals Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "ANDA205974", "marketing_category": "ANDA", "marketing_start_date": "20220819", "listing_expiration_date": "20271231"}